journal article·2018-11-12Open access

Evaluation of cellular and transcriptional targeting of breast cancer stem cells via anti-HER2 nanobody conjugated PAMAM dendrimers

Azadeh Reshadmanesh, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Farnoush Jafari Iri Sofla

Abstract

According to the cancer stem cell (CSC) theory, a small subset of cells with stem cell-like characteristics is responsible for tumor initiation, progression, and recurrence. CD44+/CD24- phenotype is assumed to be one of the main characteristics of the breast CSCs. We developed an MDA-MB-231 cell line overexpressing cell surface HER2 antigen for the evaluation of targeting efficiency of anti-HER2 nanobody (Nb)-conjugated polyamidoamine (PAMAM) polyplexes. Apoptosis-inducing tBid gene under control of CXCR1 promoter was delivered by this nanoparticle. Cellular uptake study showed higher uptake of Nb-targeted PAMAM carriers compared to non-targeted nanoparticles after 6 h of incubation. Gene expression analysis showed a significant rise in the expression of tBid in both MDA-MB-231/HER2+ and MDA-MB-231 compared to the two other cell lines. The same effect was observed after transfection with Nb-conjugated polyplexes within MDA-MB-231/HER2+ cell line compared to non-conjugated PAMAM polyplexes. We confirmed the killing efficiency of the gene construct in both MDA-MB-231/HER2+ and MDA-MB-231 cell lines by caspase 3 activity assay. These findings suggest that imposing pre-entry and post-entry restrictions on tBid killer gene might be a promising approach to specifically target the breast CSCs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University

Department of Biochemistry, School of Allied Medical Sciences, Iran University of Medical Sciences

References (52)

Show source-provided references
1. 10.1016/j.molonc.2010.04.00410.1016/j.molonc.2010.04.004 ↗
2. 10.1016/j.cell.2009.08.01710.1016/j.cell.2009.08.017 ↗
3. 10.1155/2012/70803610.1155/2012/708036 ↗
4. 10.1111/j.1582-4934.2008.00455.x10.1111/j.1582-4934.2008.00455.x ↗
5. 10.1186/bcr161010.1186/bcr1610 ↗
6. 10.1007/s10911-010-9175-z10.1007/s10911-010-9175-z ↗
7. 10.1016/0092-8674(90)90694-A10.1016/0092-8674(90)90694-A ↗
8. 10.1038/nrc302310.1038/nrc3023 ↗
9. 10.1038/sj.onc.120962810.1038/sj.onc.1209628 ↗
10. 10.1023/A:101137152399410.1023/A:1011371523994 ↗
11. 10.18632/oncotarget.341010.18632/oncotarget.3410 ↗
12. 10.1158/1078-0432.CCR-09-153210.1158/1078-0432.CCR-09-1532 ↗
13. 10.1016/j.ccr.2007.01.01310.1016/j.ccr.2007.01.013 ↗
14. 10.1242/jcs.0274110.1242/jcs.02741 ↗
15. 10.1038/sj.cgt.770086710.1038/sj.cgt.7700867 ↗
16. 10.1158/1078-0432.CCR-12-106310.1158/1078-0432.CCR-12-1063 ↗
17. 10.1016/j.cellsig.2014.08.02710.1016/j.cellsig.2014.08.027 ↗
18. 10.1038/srep0591110.1038/srep05911 ↗
19. 10.1016/j.addr.2005.09.01810.1016/j.addr.2005.09.018 ↗
20. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
21. 10.1021/bc700264g10.1021/bc700264g ↗
22. 10.1016/j.jorganchem.2004.09.03510.1016/j.jorganchem.2004.09.035 ↗
23. 10.1517/14712598.5.1.11110.1517/14712598.5.1.111 ↗
24. 10.1016/j.tibtech.2014.03.00110.1016/j.tibtech.2014.03.001 ↗
25. 10.1177/088391151556900510.1177/0883911515569005 ↗
26. 10.1016/0003-2697(75)90431-510.1016/0003-2697(75)90431-5 ↗
27. Pfaffl MW. Quantification strategies in real-time PCR. In: Bustin SA editor. A-Z of quantitative PCR. La Jolla CA: International University Line; 2004. p. 87–112.
28. 10.1007/s00018-008-7440-810.1007/s00018-008-7440-8 ↗
29. 10.1677/erc.0.008001110.1677/erc.0.0080011 ↗
30. 10.1016/0165-4608(81)90057-110.1016/0165-4608(81)90057-1 ↗
31. 10.1016/j.bbrc.2010.05.04110.1016/j.bbrc.2010.05.041 ↗
32. Soule HD et al. Isolation and characterization of spontaneously immortalized human breast epithelial cell line MCF-10. Cancer Res. 1990;50: 6075–6086.
33. 10.1177/11782234100040000410.1177/117822341000400004 ↗
34. 10.1016/j.ccr.2006.10.00810.1016/j.ccr.2006.10.008 ↗
35. 10.1158/0008-5472.CAN-07-201710.1158/0008-5472.CAN-07-2017 ↗
36. 10.1002/stem.79110.1002/stem.791 ↗
37. Yin K. The mesenchymal-like phenotype of the MDA-MB-231 cell line. In: Gunduz MG editor. Breast cancer-focusing tumor microenvironment stem cells and metastasis. InTech; 2011. p. 585–402.
38. 10.1186/bcr210810.1186/bcr2108 ↗
39. 10.1007/s12032-014-0275-210.1007/s12032-014-0275-2 ↗
40. 10.1111/cas.1242710.1111/cas.12427 ↗
41. 10.1016/S0167-4781(02)00347-010.1016/S0167-4781(02)00347-0 ↗
42. 10.1038/nrd103310.1038/nrd1033 ↗
43. 10.1155/2011/16096710.1155/2011/160967 ↗
44. 10.1016/S0021-9258(17)41848-510.1016/S0021-9258(17)41848-5 ↗
45. 10.1039/c3nr05559k10.1039/c3nr05559k ↗
46. 10.1016/S0014-3057(02)00188-X10.1016/S0014-3057(02)00188-X ↗
47. 10.1208/s12248-009-9116-110.1208/s12248-009-9116-1 ↗
48. 10.1021/bi701719910.1021/bi7017199 ↗
49. 10.1158/0008-5472.CAN-08-274110.1158/0008-5472.CAN-08-2741 ↗
50. 10.1172/JCI3939710.1172/JCI39397 ↗
51. 10.1016/j.molcel.2012.06.01410.1016/j.molcel.2012.06.014 ↗
52. 10.1016/j.abb.2015.04.00810.1016/j.abb.2015.04.008 ↗